| Literature DB >> 33061386 |
Xiuqun Gong1, Zeyu Lu2, Xiwu Feng3, Chuanqing Yu1, Min Xue1, Liang Yu1, Tao Wang1, Xiaosi Cheng1, Jun Lu4,5, Mei Zhang1.
Abstract
PURPOSE: Inflammation plays a critical role in the development of depression after intracerebral hemorrhage (ICH), while neutrophil-to-lymphocyte ratio (NLR) has been identified as a novel comprehensive inflammatory indicator in recent years. The aim of this study was to examine the association between NLR and depression after ICH. PATIENTS AND METHODS: From January 2016 to December 2018, ICH patients were prospectively enrolled. NLR was measured at admission. Depression at 3 months after ICH was diagnosed according to the Hamilton Depression Scale (HAMD).Entities:
Keywords: depression; inflammation; intracerebral hemorrhage; neutrophil-to-lymphocyte ratio
Year: 2020 PMID: 33061386 PMCID: PMC7518785 DOI: 10.2147/NDT.S269210
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Comparisons of Baseline Characteristics According to the Presence or Absence of Depression After ICH
| Variables | Total (n=372) | Depression After ICH | ||
|---|---|---|---|---|
| Depression | Non-Depression | |||
| Demographics | ||||
| Age, years, median (IQR) | 66 (56, 75) | 70 (57, 76) | 65 (56, 74) | 0.100 |
| Gender, Male, n (%) | 232 (62.4) | 63 (58.9) | 169 (63.8) | 0.378 |
| Education years, median (IQR) | 5 (4, 9) | 5 (4, 9) | 6 (4, 10) | 0.117 |
| Married, n (%) | 322 (86.6) | 92 (86.0) | 230 (86.8) | 0.347 |
| Medical history, n (%) | ||||
| Hypertension | 255 (68.5) | 74 (69.2) | 181 (68.3) | 0.872 |
| Diabetes | 50 (13.4) | 16 (15.0) | 34 (12.8) | 0.587 |
| Hyperlipidemia | 138 (37.1) | 44 (41.1) | 94 (35.5) | 0.307 |
| Coronary heart disease | 34 (9.1) | 12 (11.2) | 22 (8.3) | 0.377 |
| Atrial fibrillation | 9 (2.4) | 3 (2.8) | 6 (2.3) | 0.759 |
| Prior stroke | 127 (34.1) | 39 (36.4) | 88 (33.2) | 0.551 |
| Smoking | 91 (24.5) | 31 (29.0) | 60 (22.6) | 0.355 |
| Drinking | 94 (25.3) | 24 (22.4) | 70 (26.4) | 0.636 |
| Hematoma volume, mL, median (IQR) | 12 (8, 18) | 14 (8, 20) | 12 (8, 16) | 0.102 |
| Hematoma location, n (%) | ||||
| Frontal lobe | 9 (2.4) | 5 (4.7) | 4 (1.5) | 0.072 |
| Parietal lobe | 22 (5.9) | 10 (9.3) | 12 (4.5) | 0.075 |
| Temporal lobe | 34 (9.1) | 9 (8.4) | 25 (9.4) | 0.757 |
| Occipital lobe | 24 (6.5) | 8 (7.5) | 16 (6.0) | 0.609 |
| Basal ganglia | 290 (78.0) | 91 (85.0) | 199 (75.1) | 0.036 |
| Cerebellum | 22 (5.9) | 5 (4.7) | 17 (6.4) | 0.519 |
| Brainstem | 10 (2.7) | 2 (1.9) | 8 (3.0) | 0.535 |
| Concurrent ventricular hemorrhage | 61 (16.4) | 21 (19.6) | 40 (15.1) | 0.285 |
| Hematologic parameters | ||||
| WBC, x109/L, median (IQR) | 7.94 (6.35, 10.04) | 8.55 (6.84, 10.49) | 7.73 (6.11, 9.82) | 0.006 |
| ANC, x109/L, median (IQR) | 5.80 (3.99, 7.70) | 6.95 (5.43, 9.04) | 5.33 (3.50, 7.22) | <0.001 |
| ALC, x109/L, median (IQR) | 1.35 (1.01, 1.70) | 1.17 (0.85, 1.51) | 1.40 (1.09, 1.79) | <0.001 |
| NLR, median (IQR) | 4.14 (2.63, 6.36) | 6.15 (4.22, 9.87) | 3.55 (2.42, 5.89) | <0.001 |
| Neuropsychological function | ||||
| NIHSS score, median (IQR) | 6 (3, 11) | 12 (9, 15) | 5 (3, 8) | <0.001 |
| GCS score, median (IQR) | 15 (15, 15) | 14 (14, 15) | 15 (15, 15) | <0.001 |
| mRS score, median (IQR) | 2 (1, 4) | 4 (3, 4) | 2 (0, 3) | <0.001 |
| BI score, median (IQR) | 90 (20, 100) | 20 (20, 65) | 100 (65, 100) | <0.001 |
| MMSE score, median (IQR) | 25 (24, 26) | 25 (24, 26) | 25 (24, 26) | 0.249 |
Abbreviations: ICH, intracerebral hemorrhage; IQR, interquartile range; WBC, white blood cells; ANC, absolute neutrophil count; ALC, absolute lymphocyte count; NLR, neutrophil-to-lymphocyte ratio; NIHSS, National Institute of Health Stroke Scale; GCS, Glasgow Coma Scale; mRS, modified Rankin Scale; BI, Barthel Index; MMSE, Mini-Mental State Examination.
Comparisons of Baseline Characteristics According to NLR Tertiles
| Variables | NLR | |||
|---|---|---|---|---|
| Q1 (≤3.18, n=124) | Q2(3.18–5.91, n=124) | Q3 (>5.91, n=124) | ||
| Demographics | ||||
| Age, years, median (IQR) | 64 (54, 72) | 65.5 (56, 75) | 69 (60, 76) | 0.030 |
| Gender, Male, n (%) | 62 (50) | 83 (66.9) | 87 (70.2) | 0.002 |
| Education years, median (IQR) | 6.0 (4.0, 11.8) | 5 (4, 9) | 5 (4, 8) | 0.048 |
| Married, n (%) | 112 (90.3) | 106 (85.5) | 104 (83.9) | 0.490 |
| Medical history, n (%) | ||||
| Hypertension | 86 (69.4) | 91 (73.4) | 78 (62.9) | 0.200 |
| Diabetes | 19 (15.3) | 18 (14.5) | 13 (10.5) | 0.489 |
| Hyperlipidemia | 52 (41.9) | 43 (34.7) | 43 (34.7) | 0.393 |
| Coronary heart disease | 7 (5.6) | 15 (12.1) | 12 (9.7) | 0.205 |
| Atrial fibrillation | 2 (1.6) | 5 (4.0) | 2 (1.6) | 0.359 |
| Prior stroke | 42 (33.9) | 45 (36.3) | 40 (32.3) | 0.454 |
| Smoking | 29 (23.4) | 21 (16.9) | 40 (32.3) | 0.038 |
| Drinking | 32 (25.8) | 29 (23.4) | 33 (26.6) | 0.635 |
| Hematoma volume, mL, median (IQR) | 12 (8, 17) | 12 (8, 16) | 12 (7, 20) | 0.942 |
| Hematoma location, n (%) | ||||
| Frontal lobe | 3 (2.4) | 2 (1.6) | 4 (3.2) | 0.711 |
| Parietal lobe | 8 (6.5) | 3 (2.4) | 11 (8.9) | 0.094 |
| Temporal lobe | 10 (8.1) | 12 (9.7) | 12 (9.7) | 0.879 |
| Occipital lobe | 4 (3.2) | 8 (6.5) | 12 (9.7) | 0.118 |
| Basal ganglia | 98 (79.0) | 95 (76.6) | 97 (78.2) | 0.896 |
| Cerebellum | 8 (6.5) | 7 (5.6) | 7 (5.6) | 0.953 |
| Brainstem | 2 (1.6) | 6 (4.8) | 2 (1.6) | 0.193 |
| Concurrent ventricular hemorrhage | 16 (12.9) | 23 (18.5) | 22 (17.7) | 0.430 |
| Hematologic parameters | ||||
| WBC, x109/L, median (IQR) | 6.37 (5.11, 8.33) | 8.31(6.88, 10.18) | 9.02 (7.43, 10.70) | <0.001 |
| ANC, x109/L, median (IQR) | 3.51 (2.80, 4.71) | 6.00 (4.99, 7.68) | 7.69 (6.36, 9.75) | <0.001 |
| ALC, x109/L, median (IQR) | 1.66 (1.34, 2.06) | 1.40 (1.15, 1.69) | 1.00 (0.82, 1.23) | <0.001 |
| NLR, median (IQR) | 2.26 (1.87, 2.64) | 4.14 (3.69, 5.24) | 7.31 (6.35, 9.47) | <0.001 |
| Neuropsychological function | ||||
| NIHSS score, median (IQR) | 5 (3, 9) | 6 (4, 11) | 8 (3, 12) | 0.001 |
| GCS score, median (IQR) | 15 (15, 15) | 15 (15, 15) | 15 (14, 15) | <0.001 |
| mRS score, median (IQR) | 2 (0, 3) | 2 (1, 4) | 3 (1, 4) | <0.001 |
| BI score, median (IQR) | 100 (60, 100) | 90 (20, 100) | 60 (20, 100) | <0.001 |
| MMSE score, median (IQR) | 25 (24, 26) | 25 (24, 26) | 25 (24, 26) | 0.910 |
Abbreviations: NLR, neutrophil-to-lymphocyte ratio; IQR, interquartile range; WBC, white blood cells; ANC, absolute neutrophil count; ALC, absolute lymphocyte count; NIHSS, National Institute of Health Stroke Scale; GCS, Glasgow Coma Scale; mRS, modified Rankin Scale; BI, Barthel Index; MMSE, Mini-Mental State Examination.
Logistic Regression Model of NLR and Depression After ICH at 3 Months
| SE | OR | 95% CI for OR | ||||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Unadjusted model | 0.40 | 0.05 | 1.50 | 1.35 | 1.66 | <0.001 |
| Adjusted model | ||||||
| Model 1 | 0.41 | 0.06 | 1.51 | 1.35 | 1.67 | <0.001 |
Notes: Model 1: adjusted for age and sex. Model 2: adjusted for age, sex and risk factors (history of smoking, history of drinking, hypertension, diabetes, hyperlipidemia, atrial fibrillation). Model 3: further adjusted for variables with p < 0.05 in univariate analysis (basal ganglia lesions, baseline NIHSS score, baseline GCS score, mRS score, BI score, WBC, ANC, NLR and ALC).
Abbreviations: NLR, neutrophil-to-lymphocyte ratio; ICH, intracerebral hemorrhage; OR, odds ratio; CI, confidence interval.
Figure 1Receiver operating characteristic curves for predicting of depression following ICH. Predictive values of WBC, ANC and NLR for depression after ICH at 3-month and ALC for non-depression. Area under the curve 0.592 (95% CI, 0.530–0.653; P = 0.006) for WBC; 0.704 (95% CI, 0.647–0.761; P < 0.001) for ANC; 0.758 (95% CI, 0.702–0.814; P < 0.001) for NLR; and 0.649 (95% CI, 0.588–0.711; P < 0.001) for ALC.